Oncology Pharma (ONPH) Financial Statements
Oncology Pharma Financial Overview
Oncology Pharma's market cap is currently $1.10M. The company's EPS TTM is $-0.16; its P/E ratio is -564.71; Oncology Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -779.00 | $ -1.11K | $ -1.11K |
| Operating Income | $ -62.05K | $ -14.41M | $ -403.88K | $ -818.86K |
| EBITDA | $ 228.68K | $ -14.66M | $ -181.45K | $ -817.75K |
| Net Income | $ -104.63M | $ -97.47M | $ -207.56K | $ -850.40K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 3.96K | $ 8.95K | $ 1.80K | $ 6.71K |
| Total Assets | $ 2.12M | $ 347.55K | $ 230.85K | $ 190.54K |
| Total Debt | $ 662.08K | $ 238.38K | $ 129.41K | $ 238.05K |
| Net Debt | $ 658.12K | $ 229.43K | $ 127.61K | $ 231.34K |
| Total Liabilities | $ 875.47K | $ 517.57K | $ 294.52K | $ 403.16K |
| Stockholders' Equity | $ 1.25M | $ -170.01K | $ -63.66K | $ -212.62K |
| Cash Flow | ||||
| Free Cash Flow | $ 368.61K | $ -117.08K | $ -22.41K | $ -36.91K |
| Operating Cash Flow | $ 368.61K | $ -117.08K | $ -22.41K | $ -36.91K |
| Investing Cash Flow | $ -1.78M | $ -321.95K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.41M | $ 446.18K | $ 17.51K | $ 42.89K |
Currency in USD
